![]() |
Click to Learn More |
Tyrone's commentary:
If integrating the medical and pharmacy benefit requires that you relinquish flexibility and cost controls, the disadvantages of integration far outweigh the advantages. Disadvantages may include:
- Plan members may pay U&C (usual and customary) prices, which are higher than discounted prices
- Formulary and rebate arrangements may not be available or are significantly limited
- Plan sponsors lack authority and flexibility and are typically unable to adjudicate plan limitations, plan exclusions, enforce generic dispensing mandates or validate appropriate drug pricing
As intermediaries, non-fiduciary PBM companies profit twice on each transaction: They get fees from insurers and employers while obtaining rebates from manufacturers that are entirely hidden from public view. Across the industry, payments from pharmaceutical manufacturers to intermediaries now exceed $100 billion per year.
[Read More]
No comments:
Post a Comment